Nasdaq Stocks

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

AMAG Pharmaceuticals, Inc. AMAG incurred an adjusted (excluding one-time expenses) loss of 39 cents per share in the first quarter of 2020, narrower than the year-ago reported loss of $3.32. The Zacks Consensus Estimate was of earnings of 1 cent.

Plagued by the coronavirus-induced receding air-travel demand, LATAM Airlines Group LTM reported lackluster traffic figures for April wherein load factor (% of seats filled by passengers) deteriorated as traffic decline was more than capacity contraction.

Wix.com Ltd.’s WIX is set to report first-quarter 2020 results on May 14.

Aquestive Therapeutics (AQST) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to disco

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to disco

Support for Brazilian President Jair Bolsonaro has dropped as criticism grows of his handling of the coronavirus pandemic, according to a poll released on Tuesday, driving home his political isolation in the mounting public health crisis.

In trading on Tuesday, shares of Floor & Decor Holdings Inc (Symbol: FND) crossed above their 200 day moving average of $45.27, changing hands as high as $45.37 per share. Floor & Decor Holdings Inc shares are currently trading up about 2.4% on the day. The chart bel

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 1, Santander Consumer USA Holdings Inc's CEO, Mahesh Aditya, invested $74,800.00 into 5,000 shares of SC, for a cost per share o

Shares of the small-cap vaccine-specialist biotech jumped more than 50% after it announced that it would receive up to $388 million from a nongovernmental group to fund development of its experimental Covid-19 vaccine.

The company said it would commit to a quarterly dividend and fully expects its tenants to honor their lease commitments.

Citi’s Jason Bazinet repeated his Buy rating on the search-engine giant’s shares, while lifting his target for the stock price to $1,600, from $1,400.

After closing its acquisition of Allergan, AbbVie has a valuation that “remains at steep discount” to its pharmaceutical peers, analyst Chris Schott says.

In trading on Tuesday, shares of Cooper Companies, Inc. (Symbol: COO) crossed above their 200 day moving average of $311.81, changing hands as high as $312.41 per share. Cooper Companies, Inc. shares are currently trading up about 1.4% on the day. The chart below shows the

B2Gold Corp BTG reported first-quarter 2020 adjusted earnings per share of 10 cents, which missed the Zacks Consensus Estimate of 11 cents. However, the reported figure marked a substantial improvement from earnings of 3 cents reported in the prior-year quarter. The upside can b

As of late, it has definitely been a great time to be an investor Aclaris Therapeutics, Inc. ACRS.The stock has moved higher by 11.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest

Reata Pharmaceuticals Inc RETA reported first-quarter 2020 loss of $1.47 per share, narrower than the Zacks Consensus Estimate of a loss of $2.55.

As of late, it has definitely been a great time to be an investor Ardelyx, Inc. ARDX.The stock has moved higher by 29.1% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the sto

Silver Standard Resources Inc. SSRM is slated to report first-quarter 2020 results on May 14, after the closing bell.